Laboratory News and Research

RSS

Immune cell differences may explain sex-specific obesity responses

University of California, Riverside scientists have an explanation for why males and females respond differently to obesity.

6 Nov 2026

Study maps key regions driving inflammation in aging hearts

Scientists have long known that aging drives inflammation in the heart, but exactly how those changes are distributed throughout the organ has remained unclear.

6 Nov 2026

IITGN research explores new approach to tackling drug-resistant glioblastoma

Cancer remains among the most deadly diseases worldwide. Globally, more than 300,000 new cases of brain cancer are reported each year, with glioblastoma, an aggressive form of brain cancer, accounting for over 250,000 deaths.

6 Nov 2026

Stony Brook-developed cancer drug advances to human clinical trials

A promising new cancer chemotherapeutic agent from a taxane class of natural compounds – anti-cancer agents designed to block cell division and trigger the programmed cell death to treat sold tumors – originally developed by researchers at Stony Brook University has entered human clinical trials.

6 Nov 2026

SCAI updates consensus framework for assessing cardiogenic shock severity

The Society for Cardiovascular Angiography & Interventions (SCAI) today released the 2026 SCAI SHOCK Classification Expert Consensus Update, providing refined guidance to help clinicians from diverse settings prioritize and recognize inadequate organ perfusion across a broad range of shock presentations, assess shock severity over time, and determine whether treatment is restoring adequate circulation.

6 Nov 2026

Towards a new approach to treating chronic blood disorders

A previously unrecognised weakness in the immune defenses against certain blood neoplasms could offer a promising target for future treatments.

6 Nov 2026

Siemens Healthineers to rebrand in vitro diagnostics business as Olyrian Diagnostics

Siemens Healthineers announced today it has initiated the carve-out process for its in vitro diagnostics business, marking an important step toward establishing a standalone company that will operate under the name Olyrian Diagnostics.

From Siemens Healthineers 5 Nov 2026

Struggling with constipation? Two green kiwifruits a day may help

A narrative review of 33 publications found that consuming two fresh green kiwifruits daily for approximately four weeks can improve bowel movement frequency and gastrointestinal comfort in adults with functional constipation or constipation-predominant irritable bowel syndrome (IBS-C). Clinical studies reported broadly similar improvements with kiwifruit, psyllium, and prunes, although more research is needed to establish long-term benefits and differences between kiwifruit varieties.

5 Nov 2026

Review examines translational bottlenecks for plant-derived anti-inflammatory compounds

A review led by Professor Weidong Zhang at the School of Pharmacy, Naval Medical University, was published in Volume 2 of the journal Immunity & Inflammation on October 27, 2026. The article systematically examines the translational bottlenecks and potential solutions for plant-derived anti-inflammatory compounds.

5 Nov 2026

New AI e-nose device brings digitized smell to wearable technology

Our sense of smell shapes how we navigate our environment, but it's a sensation that's notoriously difficult to recreate in the digital world.

5 Nov 2026

CIRM grant funds new stem cell therapy to heal hearts

A new $6.9 million grant from the California Institute for Regenerative Medicine (CIRM) will support preclinical development of an investigational cell therapy for the heart created by USC Stem Cell scientists.

5 Nov 2026

ASH establishes new blood reference ranges for Duffy-null individuals

ASH has developed new reference ranges for children and adults with Duffy-null status, a common genetic trait associated with naturally lower circulating white blood cell counts that affects more than 66% of people with African or Mediterranean ancestry in the US.

5 Nov 2026

Vulnerable DNA sites make cancer cells sensitive to PARP inhibitors

A small subset of vulnerable DNA sites can make cancer cells highly sensitive to targeted drugs called PARP inhibitors, a new study shows.

5 Nov 2026

UCLA advances CRISPR gene-editing therapy for sickle cell disease

A UCLA-led team has described how they advanced an experimental CRISPR approach for sickle cell disease into a blood stem cell therapy that can be manufactured at the scale and quality required for a clinical trial.

4 Nov 2026

Bed bug infestations affect communities across all socioeconomic groups

Rather than being a poverty problem, bed bugs are actually everyone's problem.

4 Nov 2026

A study of 27,000 adults links bean products and soy compounds to lower kidney disease odds

A cross-sectional study of 27,003 adults in Northeast China found that higher consumption of processed bean products and soy isoflavones was associated with lower odds of chronic kidney disease, while plain bean intake showed no significant association. The relationship with soy isoflavones was stronger in women, although the observational findings cannot establish whether these foods protect against kidney disease.

4 Nov 2026

Comprehensive genetic map offers new hope for tuberculosis treatments

Rockefeller scientists have created the most comprehensive map to date of how essential genes interact in Mycobacterium tuberculosis (Mtb), the bacterium responsible for tuberculosis (TB).

4 Nov 2026

Deep learning method maps spatial architecture of brain cancer cells

Glioblastoma is the deadliest and most common type of malignant brain tumour in adults. One of the reasons it's almost always incurable is that individual tumour cells are very different from one another and shift dynamically between various 'states'.

4 Nov 2026

Traditional mulberry paper used to develop breathable health patch

Wearable health-monitoring devices are becoming increasingly important for personalized health care, but conventional patches often rely on substrates that restrict airflow, trap sweat, and cause skin discomfort during prolonged use.

4 Nov 2026